Insulin Deficiency Exacerbates Muscle Atrophy and Osteopenia in Chrebp Knockout Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311672 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Chihiro Ushiroda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Nutrition, Fujita Health University, Toyoake 470-1192, Japan. Hauptthemen laut MEDLINE: Insulin, Muscular Atrophy, Bone Diseases, Metabolic, Transcription Factors. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Diabetes Society Carrier Development Award, Japan Association for Diabetes Education and Care.
Abstract (Originalsprache)
Type 1 diabetes mellitus is a major risk factor for both sarcopenia and osteoporosis, primarily due to the body’s inability to utilize glucose as a result of insulin deficiency. Impairments in insulin and glucose signaling can accelerate the decline in muscle and bone health. To investigate this interaction, we examined whether insulin deficiency exacerbates muscle and bone deterioration in Chrebp knockout (KO) mice. Male wild-type (WT) and KO mice, aged 18 weeks, were intraperitoneally treated with 200 mg/kg BW streptozotocin (STZ), which selectively destroys pancreatic beta cells, thereby inducing insulin deficiency. Two weeks after STZ administration, compared with STZ-treated WT mice, STZ-treated KO mice presented significantly greater reductions in body weight and gastrocnemius muscle weight (BW: WT-vehicle vs. WT-STZ; 2.58 [−1.23, 6.39] (p = 0.21); KO-vehicle vs. KO-STZ: 8.03 [5.23, 10.82]; GA muscle: WT vehicle vs. WT STZ: 0.084 [0.047, 0.12], p < 0.0001; KO vehicle vs. KO STZ: 0.084, [0.047, 0.12], p < 0.0001). The decrease in grip strength caused by STZ administration was greater in the KO mice than in the WT mice (mean differences [95% CIs]: WT vehicle—WT STZ, 49.6. [0.9, 98.4], p = 0.046; WT STZ—KO STZ: 71.40 [29.1, 113.7], p = 0.0059; KO vehicle—KO STZ: 84.3 [51.9, 116.8], p = 0.0003). Consistent with these findings, STZ administration reduced IGF-1 expression and increased atrogin mRNA levels, with the highest levels in STZ-treated KO mice. In skeletal muscle, the changes in IGF-1 and Atrogen induced by STZ administration were significantly greater in the KO group than in the WT group (IGF-1: WT vehicle—WT STZ: 0.19 [−0.072, 0.46], p = 0.17; KO vehicle—KO STZ: 0.79 [0.53, 1.06], p < 0.0001; Atrogen: WT vehicle—WT STZ: −2.7 [−3.01, −2.29], p < 0.0001; KO vehicle—KO STZ: −3.35 [−3.71, −2.99], p < 0.0001). The BMD in the Chrebp-deficient group was greater than that in the wild-type group (WT vehicle—KO vehicle: −5.2 [−8.4, −1.9], p = 0.0014); however, the administration of STZ significantly decreased the BMD only in the KO group (WT vehicle—WT STZ: p = 0.45, KO vehicle—KO STZ: 7.2 [3.9, 10.4], p < 0.0001). These results suggest that Chrebp deficiency combined with insulin deficiency aggravates sarcopenia and osteoporosis risk. Therefore, insulin and glucose signals are important for maintaining muscle and bone mass and function. However, further studies are needed to elucidate the mechanisms by which ChREBP deletion and insulin deficiency cause osteosarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Nutrition, Fujita Health University, Toyoake 470-1192, Japan.
- Department of Endocrinology and Metabolism, Fujita Health University, Toyoake 470-1192, Japan.
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
- Food and Nutrition Service Department, Fujita Health University Hospital, Toyoake 470-1192, Japan.
ORCID-Profile: Chihiro Ushiroda, Toshinori Imaizumi, Yusuke Seino, Atsushi Suzuki, Katsumi Iizuka
Förderung
- Japan Society for the Promotion of Science
- Japan Diabetes Society Carrier Development Award
- Japan Association for Diabetes Education and Care
- Yamaguchi Endocrine Research Foundation
Zitieren
APA
Ushiroda, C., Ito, M., Yamamoto-Wada, R., Deguchi, K., Hidaka, S., Imaizumi, T., Seino, Y., Suzuki, A., Yabe, D., & Iizuka, K. (2025). Insulin Deficiency Exacerbates Muscle Atrophy and Osteopenia in Chrebp Knockout Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311672
Vancouver
Ushiroda C, Ito M, Yamamoto-Wada R, Deguchi K, Hidaka S, Imaizumi T, et al. Insulin Deficiency Exacerbates Muscle Atrophy and Osteopenia in Chrebp Knockout Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311672
BibTeX
@article{Ushiroda2025,
author = {Ushiroda, Chihiro and Ito, Mioko and Yamamoto-Wada, Risako and Deguchi, Kanako and Hidaka, Shihomi and Imaizumi, Toshinori and Seino, Yusuke and Suzuki, Atsushi and Yabe, Daisuke and Iizuka, Katsumi},
title = {Insulin Deficiency Exacerbates Muscle Atrophy and Osteopenia in Chrebp Knockout Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311672}
}
EUVIMED